Eterna Therapeutics Inc. (ERNA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Eterna Therapeutics Inc. (ERNA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.44

-0.01 (-2.00%)

At close: Jan 17, 2025, 3:59 PM

0.42

-3.50%

After-hours Jan 17, 2025, 05:55 PM EST

undefined% (undefined)

Bid	0.42
Market Cap	22.46M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-8.31
PE Ratio (ttm)	-0.05
Forward PE	n/a
Analyst	n/a

Ask	0.44
Volume	2,438,001
Avg. Volume (20D)	10,721,727
Open	0.43
Previous Close	0.45
Day's Range	0.40 - 0.50
52-Week Range	0.22 - 2.63
Beta	undefined

About ERNA

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Aug 29, 1991

Employees 8

Stock Exchange NASDAQ

Ticker Symbol ERNA

Website https://www.brooklynitx.com

Why Price Moved

3 days ago · Source

+48.22%

Eterna Therapeutics shares are trading higher afte... Unlock content with Pro Subscription

News

3 years ago · investorplace.com

7 Top-Rated Pharmaceutical Companies to Invest In for July

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest I...

3 years ago · investorplace.com

7 Best Reddit Stocks to Buy If You Have $100 to Spare

Looking to roll the dice? Consider buying one (or more) of these seven high-risk, but possibly high-return, Reddit stocks.

3 years ago · fool.com

Why Brooklyn ImmunoTherapeutics Crushed the Market Today

The biotech is bulking up with a new acquisition.

3 years ago · benzinga.com

Brooklyn ImmunoTherapeutics Stock Rises After Novellus Therapeutics Buyout Deal

Brooklyn ImmunoTherapeutics LLC (NYSE: BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered mesenchymal stem cell (MSC) therapies using mR...

3 years ago · investorplace.com

Brooklyn Immunotherapeutics Stock Is a Worthy Bet on Genetics Research

BTX stock holders will certainly want to brace for volatility. Still, the outlook's bullish as the company pursues its game-changing research.

3 years ago · businesswire.com

Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company's Future During May 25, 2021 Shareholder Update Call

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company's Future During May 25, 2021 Shareholder Update Call

3 years ago · pulse2.com

BTX Stock Price: 21.02% Increase Explanation

The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased by 21.02% today. This is why it happened.

3 years ago · businesswire.com

Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing

3 years ago · businesswire.com

Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.

3 years ago · investorplace.com

New CEO and Exclusive License Will Bolster Brooklyn Immunotherapeutics

Is change at the C-suite level a good thing for a company? The facts seem to indicate that it's a positive development for BTX stock holders.

3 years ago · businesswire.com

Christopher Rohde, Ph.D. to Join Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics announces the appointment of Christopher Rohde, Ph.D. to the Company's Scientific Advisory Board

3 years ago · benzinga.com

Publication In Breast Cancer Research Indicate Brooklyn ImmunoTherapeutics' IRX-2 May Hold Promise In Early-Stage Breast Cancer

Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF) may be used to characterize the immunologic...

3 years ago · fool.com

Why Brooklyn ImmunoTherapeutics Stock Crushed It in April

This clinical-stage biotech was one of April's brightest stars.

3 years ago · fool.com

Up 1,300% in the Past Month, Is This Mysterious Biotech a Buy?

An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum?

3 years ago · pulse2.com

BTX Stock: From $49.80 To Over $82 Pre-Market Explanation

The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased from over 64% pre-market as it went from $49.80 to over $82 pre-market. This is why it happened.

3 years ago · benzinga.com

Brooklyn Immuno Therapeutics Skyrockets: Technical Levels To Watch

Brooklyn Immuno Therapeutics Inc. (NYSE: BTX) shares are soaring Friday. The stock is likely continuing its run after the company paid $1 million towards the acquisition of a license for Factor Biosci...

3 years ago · investorplace.com

BTX Stock: The Big News That Has Brooklyn ImmunoTherapeutics Rocketing Higher

Today, investors in BTX stock appear to be on board in a big way with a major announcement from this hot meme stock and Reddit favorite. The post BTX Stock: The Big News That Has Brooklyn ImmunoTherap...

3 years ago · forbes.com

Reddit Strikes Again: Why Is A Stock You Never Heard Of Skyrocketing In Value?

Shares of Brooklyn ImmunoTherapeutics have surged more than 800% over the past month despite a lack of a major catalyst that could explain the price jump on a fundamental basis.

3 years ago · pulse2.com

BTX Stock: Over 30% Increase Intraday Explanation

The stock price of Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) increased by over 30% during intraday trading. This is why it happened.

3 years ago · businesswire.com

Brooklyn ImmunoTherapeutics Reports Inducement Grants

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Reports Inducement Grants

Load More News